ARIAD Pharmaceuticals Inc.

(ARIA)

By |

Profile

ARIAD Pharmaceuticals Inc is an oncology company. The Company is engaged in transforming the lives of cancer patients with breakthrough medicines. It commercializes & develops products and product candidates including Iclusig, Brigatinib, and AP32788.

Contact Information

Website: www.ariad.com
Email: kendra.adams@ariad.com
Main Phone: +1 617 494-0400
Address: 26 Landsdowne Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139-4234

Issuer Information

Exchange: NGS
Employees: 459
NAICS: Biological Produ
$ 23.70 $ 0.005 (0.02%)
Last Price 23.70 Change $ 0.005 Change % 0.02 Tick N/A
Bid 23.70 Bid Size 1,200.00 Ask 23.74 Ask Size 800.00
Open 23.72 High 23.73 Low 23.68 Prev Close 23.70
Last Trade Volume 12.9 mi 52 Wk Hi 23.81 52 Wk Low 4.37
Market Cap 4.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 194,200,862.00 EPS (TTM) -0.18 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 32 133
Number of Buys 18 70
Number of Sells 14 63
Net Activity -10578 755435
Last 10 Buys Shares
Paris Panayiotopoulos 1,000
Paris Panayiotopoulos 1,000
Harvey J. Berger 1,000
Harvey J. Berger 1,000
Harvey J. Berger 1,000
Harvey J. Berger 1,000
Sarah J. Schlesinger 1,000
Sarah J. Schlesinger 1,000
Harvey J. Berger 1,000
Harvey J. Berger 1,000
Last 10 Sell Shares
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Timothy P. Clackson 1,000
Hugh M. Cole 1,000
Timothy P. Clackson 1,000
Athanase Lavidas 1,000
Massimo Radaelli 1,000
Athanase Lavidas 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 13 13 13 13
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 11 10.6 10.6 11
Standard Deviation 1.83 1.82 1.82 1.83
Date of Most Recent Estimate 07/29/16 07/29/16 07/29/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2 2.2 2.2 2.2